aluates Reports

$ 0.0

Automative

Global Migraine Market Insights, Forecast to 2029

Published Date: August 2023

Report Code: QYRE-Auto-35X5819

Global Migraine Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Migraine Market Insights, Forecast to 2029

Code: QYRE-Auto-35X5819

Report

August 2023

Pages:108

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

GlaxoSmithKline PLC

Allergan plc

Amgen Inc

Eli Lilly

Teva Pharma

Biohaven Pharma

Abbott Laboratories

Johnson & Johnson

Valeant Pharma

Migraine Market Size

The global Migraine market is projected to grow from US$ 5757 million in 2023 to US$ 9237.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.

Migraine Market

A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. Associated symptoms may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is generally made worse by physical activity.

Market Analysis and Insights: Global Migraine Market

Globally, approximately 15% of people are affected by migraines. It most often starts at puberty and is worst during middle age. As of 2016 migraines is one of the most common causes of disability.

Report Includes

This report presents an overview of global market for Migraine market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Migraine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Migraine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Migraine revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Migraine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Migraine revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Abbott Laboratories and Johnson & Johnson, etc.

Scope of Migraine Market Report

Report Metric	Details
Report Name	Migraine Market
Accounted market size in 2023	US$ 5757 million
Forecasted market size in 2029	US$ 9237.6 million
CAGR	8.2
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Oral Injectable Nasal Sprays Others
Segment by Application	Hospitals Clinics Home Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Abbott Laboratories, Johnson & Johnson, Valeant Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Migraine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Migraine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Migraine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Migraine Market growing?

Ans: The Migraine Market witnessing a CAGR of 8.2 during the forecast period 2023-2029.

What is the Migraine Market size in 2029?

Ans: The global Migraine market is projected to grow from US$ 5757 million in 2023 to US$ 9237.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.

Who are the main players in the Migraine Market report?

Ans: The main players in the Migraine Market are Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Abbott Laboratories, Johnson & Johnson, Valeant Pharma

What are the Application segmentation covered in the Migraine Market report?

Ans: The Applications covered in the Migraine Market report are Hospitals, Clinics, Home Care

What are the Type segmentation covered in the Migraine Market report?

Ans: The Types covered in the Migraine Market report are Oral, Injectable, Nasal Sprays, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Migraine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Oral

1.2.3 Injectable

1.2.4 Nasal Sprays

1.2.5 Others

1.3 Market by Application

1.3.1 Global Migraine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Home Care

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Migraine Market Perspective (2018-2029)

2.2 Global Migraine Growth Trends by Region

2.2.1 Migraine Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Migraine Historic Market Size by Region (2018-2023)

2.2.3 Migraine Forecasted Market Size by Region (2024-2029)

2.3 Migraine Market Dynamics

2.3.1 Migraine Industry Trends

2.3.2 Migraine Market Drivers

2.3.3 Migraine Market Challenges

2.3.4 Migraine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Migraine by Players

3.1.1 Global Migraine Revenue by Players (2018-2023)

3.1.2 Global Migraine Revenue Market Share by Players (2018-2023)

3.2 Global Migraine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Migraine, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Migraine Market Concentration Ratio

3.4.1 Global Migraine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Migraine Revenue in 2022

3.5 Global Key Players of Migraine Head office and Area Served

3.6 Global Key Players of Migraine, Product and Application

3.7 Global Key Players of Migraine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Migraine Breakdown Data by Type

4.1 Global Migraine Historic Market Size by Type (2018-2023)

4.2 Global Migraine Forecasted Market Size by Type (2024-2029)

5 Migraine Breakdown Data by Application

5.1 Global Migraine Historic Market Size by Application (2018-2023)

5.2 Global Migraine Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Migraine Market Size (2018-2029)

6.2 North America Migraine Market Size by Type

6.2.1 North America Migraine Market Size by Type (2018-2023)

6.2.2 North America Migraine Market Size by Type (2024-2029)

6.2.3 North America Migraine Market Share by Type (2018-2029)

6.3 North America Migraine Market Size by Application

6.3.1 North America Migraine Market Size by Application (2018-2023)

6.3.2 North America Migraine Market Size by Application (2024-2029)

6.3.3 North America Migraine Market Share by Application (2018-2029)

6.4 North America Migraine Market Size by Country

6.4.1 North America Migraine Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Migraine Market Size by Country (2018-2023)

6.4.3 North America Migraine Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Migraine Market Size (2018-2029)

7.2 Europe Migraine Market Size by Type

7.2.1 Europe Migraine Market Size by Type (2018-2023)

7.2.2 Europe Migraine Market Size by Type (2024-2029)

7.2.3 Europe Migraine Market Share by Type (2018-2029)

7.3 Europe Migraine Market Size by Application

7.3.1 Europe Migraine Market Size by Application (2018-2023)

7.3.2 Europe Migraine Market Size by Application (2024-2029)

7.3.3 Europe Migraine Market Share by Application (2018-2029)

7.4 Europe Migraine Market Size by Country

7.4.1 Europe Migraine Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Migraine Market Size by Country (2018-2023)

7.4.3 Europe Migraine Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Migraine Market Size (2018-2029)

8.2 China Migraine Market Size by Type

8.2.1 China Migraine Market Size by Type (2018-2023)

8.2.2 China Migraine Market Size by Type (2024-2029)

8.2.3 China Migraine Market Share by Type (2018-2029)

8.3 China Migraine Market Size by Application

8.3.1 China Migraine Market Size by Application (2018-2023)

8.3.2 China Migraine Market Size by Application (2024-2029)

8.3.3 China Migraine Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Migraine Market Size (2018-2029)

9.2 Asia Migraine Market Size by Type

9.2.1 Asia Migraine Market Size by Type (2018-2023)

9.2.2 Asia Migraine Market Size by Type (2024-2029)

9.2.3 Asia Migraine Market Share by Type (2018-2029)

9.3 Asia Migraine Market Size by Application

9.3.1 Asia Migraine Market Size by Application (2018-2023)

9.3.2 Asia Migraine Market Size by Application (2024-2029)

9.3.3 Asia Migraine Market Share by Application (2018-2029)

9.4 Asia Migraine Market Size by Region

9.4.1 Asia Migraine Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Migraine Market Size by Region (2018-2023)

9.4.3 Asia Migraine Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Migraine Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Migraine Market Size by Type

10.2.1 Middle East, Africa, and Latin America Migraine Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Migraine Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Migraine Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Migraine Market Size by Application

10.3.1 Middle East, Africa, and Latin America Migraine Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Migraine Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Migraine Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Migraine Market Size by Country

10.4.1 Middle East, Africa, and Latin America Migraine Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Migraine Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Migraine Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Migraine Introduction

11.1.4 Pfizer Revenue in Migraine Business (2018-2023)

11.1.5 Pfizer Recent Developments

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Details

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Migraine Introduction

11.2.4 GlaxoSmithKline Revenue in Migraine Business (2018-2023)

11.2.5 GlaxoSmithKline Recent Developments

11.3 Allergan

11.3.1 Allergan Company Details

11.3.2 Allergan Business Overview

11.3.3 Allergan Migraine Introduction

11.3.4 Allergan Revenue in Migraine Business (2018-2023)

11.3.5 Allergan Recent Developments

11.4 Amgen

11.4.1 Amgen Company Details

11.4.2 Amgen Business Overview

11.4.3 Amgen Migraine Introduction

11.4.4 Amgen Revenue in Migraine Business (2018-2023)

11.4.5 Amgen Recent Developments

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Migraine Introduction

11.5.4 Eli Lilly Revenue in Migraine Business (2018-2023)

11.5.5 Eli Lilly Recent Developments

11.6 Teva Pharma

11.6.1 Teva Pharma Company Details

11.6.2 Teva Pharma Business Overview

11.6.3 Teva Pharma Migraine Introduction

11.6.4 Teva Pharma Revenue in Migraine Business (2018-2023)

11.6.5 Teva Pharma Recent Developments

11.7 Biohaven Pharma

11.7.1 Biohaven Pharma Company Details

11.7.2 Biohaven Pharma Business Overview

11.7.3 Biohaven Pharma Migraine Introduction

11.7.4 Biohaven Pharma Revenue in Migraine Business (2018-2023)

11.7.5 Biohaven Pharma Recent Developments

11.8 Abbott Laboratories

11.8.1 Abbott Laboratories Company Details

11.8.2 Abbott Laboratories Business Overview

11.8.3 Abbott Laboratories Migraine Introduction

11.8.4 Abbott Laboratories Revenue in Migraine Business (2018-2023)

11.8.5 Abbott Laboratories Recent Developments

11.9 Johnson & Johnson

11.9.1 Johnson & Johnson Company Details

11.9.2 Johnson & Johnson Business Overview

11.9.3 Johnson & Johnson Migraine Introduction

11.9.4 Johnson & Johnson Revenue in Migraine Business (2018-2023)

11.9.5 Johnson & Johnson Recent Developments

11.10 Valeant Pharma

11.10.1 Valeant Pharma Company Details

11.10.2 Valeant Pharma Business Overview

11.10.3 Valeant Pharma Migraine Introduction

11.10.4 Valeant Pharma Revenue in Migraine Business (2018-2023)

11.10.5 Valeant Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

GlaxoSmithKline PLC

Allergan plc

Amgen Inc

Eli Lilly

Teva Pharma

Biohaven Pharma

Abbott Laboratories

Johnson & Johnson

Valeant Pharma

List of Tables

Table 1. Global Migraine Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Oral

Table 3. Key Players of Injectable

Table 4. Key Players of Nasal Sprays

Table 5. Key Players of Others

Table 6. Global Migraine Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 7. Global Migraine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global Migraine Market Size by Region (2018-2023) & (US$ Million)

Table 9. Global Migraine Market Share by Region (2018-2023)

Table 10. Global Migraine Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 11. Global Migraine Market Share by Region (2024-2029)

Table 12. Migraine Market Trends

Table 13. Migraine Market Drivers

Table 14. Migraine Market Challenges

Table 15. Migraine Market Restraints

Table 16. Global Migraine Revenue by Players (2018-2023) & (US$ Million)

Table 17. Global Migraine Revenue Share by Players (2018-2023)

Table 18. Global Top Migraine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine as of 2022)

Table 19. Global Migraine Industry Ranking 2021 VS 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by Migraine Revenue (CR5 and HHI) & (2018-2023)

Table 21. Global Key Players of Migraine, Headquarters and Area Served

Table 22. Global Key Players of Migraine, Product and Application

Table 23. Global Key Players of Migraine, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Migraine Market Size by Type (2018-2023) & (US$ Million)

Table 26. Global Migraine Revenue Market Share by Type (2018-2023)

Table 27. Global Migraine Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 28. Global Migraine Revenue Market Share by Type (2024-2029)

Table 29. Global Migraine Market Size by Application (2018-2023) & (US$ Million)

Table 30. Global Migraine Revenue Share by Application (2018-2023)

Table 31. Global Migraine Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 32. Global Migraine Revenue Share by Application (2024-2029)

Table 33. North America Migraine Market Size by Type (2018-2023) & (US$ Million)

Table 34. North America Migraine Market Size by Type (2024-2029) & (US$ Million)

Table 35. North America Migraine Market Size by Application (2018-2023) & (US$ Million)

Table 36. North America Migraine Market Size by Application (2024-2029) & (US$ Million)

Table 37. North America Migraine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. North America Migraine Market Size by Country (2018-2023) & (US$ Million)

Table 39. North America Migraine Market Size by Country (2024-2029) & (US$ Million)

Table 40. Europe Migraine Market Size by Type (2018-2023) & (US$ Million)

Table 41. Europe Migraine Market Size by Type (2024-2029) & (US$ Million)

Table 42. Europe Migraine Market Size by Application (2018-2023) & (US$ Million)

Table 43. Europe Migraine Market Size by Application (2024-2029) & (US$ Million)

Table 44. Europe Migraine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 45. Europe Migraine Market Size by Country (2018-2023) & (US$ Million)

Table 46. Europe Migraine Market Size by Country (2024-2029) & (US$ Million)

Table 47. China Migraine Market Size by Type (2018-2023) & (US$ Million)

Table 48. China Migraine Market Size by Type (2024-2029) & (US$ Million)

Table 49. China Migraine Market Size by Application (2018-2023) & (US$ Million)

Table 50. China Migraine Market Size by Application (2024-2029) & (US$ Million)

Table 51. Asia Migraine Market Size by Type (2018-2023) & (US$ Million)

Table 52. Asia Migraine Market Size by Type (2024-2029) & (US$ Million)

Table 53. Asia Migraine Market Size by Application (2018-2023) & (US$ Million)

Table 54. Asia Migraine Market Size by Application (2024-2029) & (US$ Million)

Table 55. Asia Migraine Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 56. Asia Migraine Market Size by Region (2018-2023) & (US$ Million)

Table 57. Asia Migraine Market Size by Region (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Migraine Market Size by Type (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Migraine Market Size by Type (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Migraine Market Size by Application (2018-2023) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Migraine Market Size by Application (2024-2029) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Migraine Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 63. Middle East, Africa, and Latin America Migraine Market Size by Country (2018-2023) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Migraine Market Size by Country (2024-2029) & (US$ Million)

Table 65. Pfizer Company Details

Table 66. Pfizer Business Overview

Table 67. Pfizer Migraine Product

Table 68. Pfizer Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 69. Pfizer Recent Developments

Table 70. GlaxoSmithKline Company Details

Table 71. GlaxoSmithKline Business Overview

Table 72. GlaxoSmithKline Migraine Product

Table 73. GlaxoSmithKline Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 74. GlaxoSmithKline Recent Developments

Table 75. Allergan Company Details

Table 76. Allergan Business Overview

Table 77. Allergan Migraine Product

Table 78. Allergan Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 79. Allergan Recent Developments

Table 80. Amgen Company Details

Table 81. Amgen Business Overview

Table 82. Amgen Migraine Product

Table 83. Amgen Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 84. Amgen Recent Developments

Table 85. Eli Lilly Company Details

Table 86. Eli Lilly Business Overview

Table 87. Eli Lilly Migraine Product

Table 88. Eli Lilly Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 89. Eli Lilly Recent Developments

Table 90. Teva Pharma Company Details

Table 91. Teva Pharma Business Overview

Table 92. Teva Pharma Migraine Product

Table 93. Teva Pharma Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 94. Teva Pharma Recent Developments

Table 95. Biohaven Pharma Company Details

Table 96. Biohaven Pharma Business Overview

Table 97. Biohaven Pharma Migraine Product

Table 98. Biohaven Pharma Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 99. Biohaven Pharma Recent Developments

Table 100. Abbott Laboratories Company Details

Table 101. Abbott Laboratories Business Overview

Table 102. Abbott Laboratories Migraine Product

Table 103. Abbott Laboratories Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 104. Abbott Laboratories Recent Developments

Table 105. Johnson & Johnson Company Details

Table 106. Johnson & Johnson Business Overview

Table 107. Johnson & Johnson Migraine Product

Table 108. Johnson & Johnson Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 109. Johnson & Johnson Recent Developments

Table 110. Valeant Pharma Company Details

Table 111. Valeant Pharma Business Overview

Table 112. Valeant Pharma Migraine Product

Table 113. Valeant Pharma Revenue in Migraine Business (2018-2023) & (US$ Million)

Table 114. Valeant Pharma Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Migraine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Migraine Market Share by Type: 2022 VS 2029

Figure 3. Oral Features

Figure 4. Injectable Features

Figure 5. Nasal Sprays Features

Figure 6. Others Features

Figure 7. Global Migraine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 8. Global Migraine Market Share by Application: 2022 VS 2029

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Home Care Case Studies

Figure 12. Migraine Report Years Considered

Figure 13. Global Migraine Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global Migraine Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Migraine Market Share by Region: 2022 VS 2029

Figure 16. Global Migraine Market Share by Players in 2022

Figure 17. Global Top Migraine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by Migraine Revenue in 2022

Figure 19. North America Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America Migraine Market Share by Type (2018-2029)

Figure 21. North America Migraine Market Share by Application (2018-2029)

Figure 22. North America Migraine Market Share by Country (2018-2029)

Figure 23. United States Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Canada Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Europe Migraine Market Size YoY (2018-2029) & (US$ Million)

Figure 26. Europe Migraine Market Share by Type (2018-2029)

Figure 27. Europe Migraine Market Share by Application (2018-2029)

Figure 28. Europe Migraine Market Share by Country (2018-2029)

Figure 29. Germany Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. France Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. U.K. Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Italy Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Russia Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Nordic Countries Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. China Migraine Market Size YoY (2018-2029) & (US$ Million)

Figure 36. China Migraine Market Share by Type (2018-2029)

Figure 37. China Migraine Market Share by Application (2018-2029)

Figure 38. Asia Migraine Market Size YoY (2018-2029) & (US$ Million)

Figure 39. Asia Migraine Market Share by Type (2018-2029)

Figure 40. Asia Migraine Market Share by Application (2018-2029)

Figure 41. Asia Migraine Market Share by Region (2018-2029)

Figure 42. Japan Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. South Korea Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. China Taiwan Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Southeast Asia Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. India Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Australia Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Migraine Market Size YoY (2018-2029) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Migraine Market Share by Type (2018-2029)

Figure 50. Middle East, Africa, and Latin America Migraine Market Share by Application (2018-2029)

Figure 51. Middle East, Africa, and Latin America Migraine Market Share by Country (2018-2029)

Figure 52. Brazil Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Mexico Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Turkey Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Israel Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. GCC Countries Migraine Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Pfizer Revenue Growth Rate in Migraine Business (2018-2023)

Figure 59. GlaxoSmithKline Revenue Growth Rate in Migraine Business (2018-2023)

Figure 60. Allergan Revenue Growth Rate in Migraine Business (2018-2023)

Figure 61. Amgen Revenue Growth Rate in Migraine Business (2018-2023)

Figure 62. Eli Lilly Revenue Growth Rate in Migraine Business (2018-2023)

Figure 63. Teva Pharma Revenue Growth Rate in Migraine Business (2018-2023)

Figure 64. Biohaven Pharma Revenue Growth Rate in Migraine Business (2018-2023)

Figure 65. Abbott Laboratories Revenue Growth Rate in Migraine Business (2018-2023)

Figure 66. Johnson & Johnson Revenue Growth Rate in Migraine Business (2018-2023)

Figure 67. Valeant Pharma Revenue Growth Rate in Migraine Business (2018-2023)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Internal Neuromodulation Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24F2529

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Acetaminophen - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-26Z11859

Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Global Muscle Pain Relief Patches Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6F17019

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

Global Muscle & Joint Pain Relief Patches Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0S17129

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions